WelGrace Research Pharmaceuticals
Products Under Development

In suitable containers:
  • WRG-551 Injection  (1mg/mL) (Anti-coagulant and antithrombotic)
  • WRG-508 Infusion (0.4 mg/mL) Antihypertensive
  • WRG-509  Injection (5mg/mL) Antiepileptic Vacomycin Infusion (5mg/mL)
  • WRG-570 (1 mg/mL) Antiplatelet
  • WRG-52150 Infusion (10 mg/mL) Antihypertensive        
For more information, contact:
Mr. George Owoo
President and CEO
764 Porter Circle, Lindenhurst, IL 60046
Email:
owoog@welgrace.com
Telephone  224-372-7918, 908-295-1985  FAX 224-372-7464